Enhanced epithelial cell turnover associated with p53 accumulation and high p21(WAF1/CIP1) expression in ulcerative colitis

Modern Pathology

Volumn 12, Issue 6, 1999, Pages 604-611

  Arai, Nobuyasu ^a   Mitomi, Hiroyuki ^a,b   Ohtani, Yoshimasa ^a   Igarashi, Masahiro ^a   Kakita, Akira ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; Cell proliferation; Immunohistochemistry; p21(WAF1 CIP1); p53; Ulcerative colitis

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; CELL METABOLISM; CELL PROLIFERATION; COLON BIOPSY; COLON POLYP; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; ULCERATIVE COLITIS;

ADULT; APOPTOSIS; BIOPSY; CELL COUNT; CELL DIVISION; COLITIS, ULCERATIVE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; INTESTINE, LARGE; KI-67 ANTIGEN; MITOTIC INDEX; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033003380     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31: 800-6.
2. Yamada M, Ohkusa T, Okayasu I. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 1992;33:1521-7.
3. Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996;39:87-92.
4. Allan A, Bristol JB, Williamson RCN. Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse. Gut 1985;26:999-1003.
5. Serafini EP, Kirk AP, Chambers TJ. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut 1981;22: 648-52.
6. Biasco G, Paganelli GM, Miglioli M, Brillanti S, Di Febo G, Gizzi G, et al. Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res 1990;50:1156-9.
7. Noffsinger AE, Miller MA, Cusi MV, Fenoglio-Preiser CM. The pattern of cell proliferation in neoplastic and non-neoplastic lesions of ulcerative colitis. Cancer 1996;78:2307-12.
8. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996;180:152-9.
9. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11.
10. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992;71: 543-6.
11. Krishna M, Woda B, Savas L, Baker S, Banner B. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod Pathol 1995;8: 654-7.
12. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-78.
13. Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR, et al. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 1994;25: 1069-74.
14. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
15. 1 cyclin-dependent kinases. Cell 1993;75:805-16.
16. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
17. 1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
18. WAF1/CIP1 expression in the absence of p53. Oncogene 1994;9:3397-406.
19. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995;267: 1018-21.
20. WAF1/CIP1/SDI1 and p53 proteins in formalin-fixed, paraffin-embedded tissue sections of colorectal carcinoma. Hum Pathol 1996;27:912-6.
21. WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol 1996;179:248-53.
22. Kerr JFR, Gobé GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol 1995;46:1-27.
23. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
24. Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35:1419-23.
25. Arai T, Kida Y, Harmon BV, Gobé GC. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br J Cancer 1996;74:406-12.
26. Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, et al. p53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol 1992;166:235-41.
27. Kallakury BVS, Figge J, Ross JS, Fisher HAG, Figge HL, Jennings TA. Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma. Hum Pathol 1994;25:92-7.
28. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143-51.
29. Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997;108:26-34.
30. Lundberg JON, Hellström PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673-4.